Status | Study |
Recruiting |
Study Name: Biomarkers for Early Detection of Ovarian Cancer Using Uterine Lavage Condition: Ovarian Cancer Ovarian Carcinoma Fallopian Tube Cancer Date: 2017-05-03 Interventions: Procedure: Uterine lavage Uter |
Not yet recruiting |
Study Name: Proof-of-concept Study of Birinapant in Combination With Platinum Based Chemotherapy in Subjects With High Grade Serous Carcinomas Condition: Advanced Newly Diagnosed or Recurrent High Grade Serous Carcinomas (HGSC) Date: 2016-04-22 Interventions: Drug: Birinapant Birinapant - |
Recruiting |
Study Name: Copanlisib in Treating Patients With Persistent or Recurrent Endometrial Cancer Condition: Endometrial Endometrioid Adenocarcinoma Endometrial Mixed Adenocarcinoma Date: 2016-03-30 Interventions: Drug: Copanlisib Given IV |
Recruiting |
Study Name: Trial of Cisplatin Plus Radiation Followed by Carbo and Taxol Vs. Sandwich Therapy of Carbo and Taxol Followed Radiation Then Further Carbo and Taxol Condition: Endometrial Clear Cell Adenocarcinoma Endometrial Serous Adenocarcinom Date: 2015-07-09 Interventions: Drug: Cisplatin Given IV |
Recruiting |
Study Name: A Phase II Evaluation of Afatinibin Patients With Persistent or Recurrent HER2-positive Uterine Serous Carcinoma Condition: HER2/Neu+ Uterine Serous Carcinoma Date: 2015-07-02 Interventions: Drug: Afatinib Afatinib, 40 mg orally once daily on a 21 day cycle for the first 12 weeks, then every 28 |
Recruiting |
Study Name: To Assess the Safety of Continuous IV Administration of Plerixafor in Patients With Advanced Pancreatic, Ovarian and Colorectal Cancers Condition: Pancreatic Adenocarcinoma Metastatic Ovarian Serous Adenocarcinoma Date: 2014-07-01 Interventions: Drug: Plerixafor A continuous 7 day intravenous infusion, starting at a dose of 20 ug/kg/hr, and subsequ |
Not yet recruiting |
Study Name: Paclitaxel and Intraperitoneal Carboplatin Followed by Radiation Therapy in Treating Patients With Stage IIIC-IV Uterine Cancer Condition: Endometrial Serous Adenocarcinoma Stage IIIA Uterine Corpus Can Date: 2014-04-10 Interventions: Drug: Paclitaxel Given IV |
Recruiting |
Study Name: Trametinib in Treating Patients With Recurrent or Progressive Low-Grade Ovarian Cancer or Peritoneal Cavity Cancer Condition: Micropapillary Serous Carcinoma Ovarian S Date: 2014-03-28 Interventions: Other: Laboratory Biomarker Analysis |
Active, not recruiting |
Study Name: Dalantercept in Treating Patients With Recurrent or Persistent Endometrial Cancer Condition: Endometrial Adenocarcinoma Endometrial Adenosquamous Carcinoma Date: 2012-07-15 Interventions: Biological: Dalantercept Given |
Active, not recruiting |
Study Name: Radical Fimbriectomy for Young BRCA Mutation Carriers Condition: BRCA1 Mutation BRCA2 Mutation Date: 2012-05-15 Interventions: Procedure: Radical fimbriectomy |